Migraine breakthrough for millions of sufferers as NHS to offer revolutionary treatment

The regulator said its approval of groundbreaking Rimegepant marks a 'step-change in treatment' for the 'invisible disability that affects all aspects of life'

Related Keywords

United Kingdom ,London ,City Of ,Helen Knight ,Peter Goadsby ,Toby Cousens ,Pfizer ,National Institute For Health ,King College London ,National Institute ,Care Excellence ,Prof Peter Goadsby ,College London ,Pfizer United Kingdom ,Medicine ,Nice ,